Avita Medical awarded $53.9 million US Government Contract

Avita Medical awarded $53.9 million US Government Contract

Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a medical device company specializing in the treatment of wounds and skin defects, has been awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA) worth up to USD$53.9 million for late-stage clinical development and procurement of its ReCell® Autologous Cell Harvesting Device under a US mass casualty preparedness program.
The contract, which will run for five years, commits funding of USD$16.9m to support Avita’s ongoing US clinical regulatory programme towards FDA Premarket Approval (PMA) and to procure more than 5,000 ReCell® devices to establish an inventory so that ReCell can be deployed to help deal with a mass casualty scenario involving burn injuries. READ MORE

No Comments

Sorry, the comment form is closed at this time.